SCHEMBL6070128

SCHEMBL6070128

[O-][S+]1c2ccc(Cl)cc2Cc2cc(Cl)ccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 2/20 0.37
HTR2C P28335 3/20 0.36
HTR2A P28223 2/20 0.36
HTR2B P41595 2/20 0.36
METAP1 P53582 1/20 0.36
HTT P42858 1/20 0.36
PNMT P11086 1/20 0.34
CMA1 P23946 1/20 0.33
TP53 P04637 1/20 0.32
CYP19A1 P11511 2/20 0.31
CYP11B1 P15538 2/20 0.31
CYP11B2 P19099 2/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA4 P22748 1/20 0.31
CA6 P23280 1/20 0.31
ADRA2A P08913 1/20 0.31
ADRA2B P18089 1/20 0.31
ADRA2C P18825 1/20 0.31
DRD4 P21917 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL37076 0.91 CA1 (0.33) AHRHTR2CHTR2AHTR2BMETAP1
SCHEMBL11516655 0.91 CA1 (0.33) AHRHTR2CHTR2AHTR2BMETAP1
SCHEMBL6070528 0.85 CYP1A2 (0.42) HTTPGR
SCHEMBL11661088 0.85 PGR (0.33) HTR2CHTR2AHTR2BMETAP1PNMT
SCHEMBL472580 0.85 AHR (0.36) AHRPNMTCYP19A1
Anthraquinone SCHEMBL9789080 0.81 MAOA (0.43) METAP1
9,10-Phenanthrenequinone SCHEMBL11210917 0.80 S100A4 (0.49) METAP1HTT
SCHEMBL15281929 0.79 CHRM2 (0.32) ADRA2ADRD4HSP90AA1
SCHEMBL11751062 0.79 HTT (0.39) AHRHTR2CHTR2AHTR2BHTT
SCHEMBL1155668 0.79 DRD2 (0.35) AHRMETAP1CMA1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7126011-B2 Reacting 2-chlorothiobenzoyl chloride with aromatic compound; drug for psychological disorder therapy; photopolymerization sensitizer PROM LIMITED (GB) 2006-10-24 US disclosed
EP-1334096-B1 FRIEDEL-CRAFT PROCESS FOR THE PREPARATION OF THIOXANTHONES PROM LTD (GB) 2004-07-28 EP disclosed
US-20030229233-A1 Process for the preparation of thioxanthones PROM LIMITED (GB) 2003-12-11 US disclosed
EP-1334096-A1 FRIEDEL-CRAFT PROCESS FOR THE PREPARATION OF THIOXANTHONES Prom Limited (GB) 2003-08-13 EP disclosed
WO-2002040464-A1 FRIEDEL-CRAFT PROCESS FOR THE PREPARATION OF THIOXANTHONES PROM LIMITED (GB) 2002-05-23 WO disclosed
US-4101558-A Process for preparing thioxanthones THE SHERWIN-WILLIAMS COMPANY (US) 1978-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030229233-A1 Process for the preparation of thioxanthones TST, TPST2, SULT2A1 AHR 136/4885HTR2C 202/4885HTR2A 335/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.